January book-to-bill is running hotter than Q4 per the CEO, yet Q1 revenue guidance of $800-830M barely moves off Q4's $801M.
Thesis: Order intake is genuinely strong: B2B 1.2, semis 1.27, backlog at $1.3B with five months coverage, and orders at three-year highs across every channel and region. But the P&L is not reflecting it. SG&A grew 13% in two quarters against 1.7% guided revenue growth. EBITDA margin compressed from 9.6% to 8.8%. 42% of operating cash flow came from securitizing receivables. The market owns the order data and is pricing in execution on conversion. If Q1 delivers flat revenue with expanding SG&A again, the Backlog Fortress narrative cracks and the stock re-rates on earnings quality.
Verdict: HOLD — Conviction: MEDIUM
Catalyst: Q1 results in May: three checkpoints. Gross margin at or above 19.9%, Newport drag at low end of 50-75bps, and backlog extending beyond 4.9 months. Beat-and-raise validates the backlog thesis. Flat guide with rising SG&A validates the bear.
Key Risk: SG&A guided to $153M in Q1 versus $135M two quarters ago, a 13% increase against 1.7% guided revenue growth. Operating leverage running in reverse while management narrates acceleration.
The Tell: In closing remarks, unprompted, Smejkal said: 'The book-to-bill in January '26 is really building our momentum and setting this for a really successful year.' He volunteered January order data to compensate for a Q1 revenue guide that is flat sequential. He is telling you the orders are real because the revenue guide cannot say it for him.
Friction Level: MODERATE_FRICTION — Both sides agree B2B is 1.2 and backlog hit $1.3B. The disagreement is whether that converts to P&L growth or whether it is supply-securing behavior that flattens once lead times normalize. Q1 guide is flat either way.
2025Q4 · Feb 4, 2026
No majority across 5 readings2 HOLD · 2 LONG · 1 SHORTRead the full call
Orders at Three-Year Highs, Revenue Guide Flat Sequential
Order intake is genuinely strong: B2B 1.2, semis 1.27, backlog at $1.3B with five months coverage, and orders at three-year highs across every channel and region. But the P&L is not reflecting it. SG&A grew 13% in two quarters against 1.7% guided revenue growth. EBITDA margin compressed from 9.6% to 8.8%. 42% of operating cash flow came from securitizing receivables. The market owns the order data and is pricing in execution on conversion. If Q1 delivers flat revenue with expanding SG&A again, the Backlog Fortress narrative cracks and the stock re-rates on earnings quality.
In closing remarks, unprompted, Smejkal said: 'The book-to-bill in January '26 is really building our momentum and setting this for a really successful year.' He volunteered January order data to compensate for a Q1 revenue guide that is flat sequential. He is telling you the orders are real because the revenue guide cannot say it for him.
Backlog of $1.3B represents 4.9 months of coverage, up 14% sequentially. Orders at three-year highs across all product technologies, all channels, all regions. Semis B2B of 1.27 confirms real demand, not channel stuffing on Vishay's own inventory which fell $759M.
Metals surcharge pushed through in October as first mover in the industry, with second increase already in discussion. Annual contract ASP declines came in below historical norms because Vishay traded price for volume. Management states 2026 ASP decline will be lower than historical.
CEO says 2026 is the year to take off while Q1 revenue guide of $800-830M is flat to up 3.7% sequentially off $801M. SG&A grew 13% in two quarters against 1.7% guided revenue growth. Confidence language increased, guidance number did not follow.
Vishay's AI exposure is multiphase DC-DC converters, tantalum polymer capacitors, and 800V power management. Commodity edge of the AI supply chain. No proprietary moat, no pricing power against competitors in these segments. The label carries the multiple.
$400-440M capex in 2026, peak of five-year expansion, with more than half allocated to 12-inch Germany fab. Management explicitly guides capital intensity down to 5-6% after peak. Capex committed and allocated, not aspirational.
CEO addressed memory price inflation with specific segment exposure and stated no revenue impact forecast. CFO walked through exact capex allocation across fab, capacitors, tantalum, inductors. M&A question answered with clear timing tied to capex peak.
Customers ordering to secure supply against extended diode/MOSFET lead times and pre-Lunar New Year positioning. Distribution inventory drawing down from 23 to 22 weeks even as orders hit three-year highs, meaning channel is consuming not stocking.
+68
CONFIDENT"Smejkal gave specific, unprompted numbers throughout: January B2B hotter than Q4, $230M capex allocated to 12-inch fab, Newport drag quantified at 50-75bps. He closed with a forward commitment about momentum rather than hedging."
Rich transcript with specific numbers on every major metric. Management answered capex allocation, memory exposure, and M&A questions directly. Gap exists on how backlog converts given flat revenue guide.
Q1 results in May: three checkpoints. Gross margin at or above 19.9%, Newport drag at low end of 50-75bps, and backlog extending beyond 4.9 months. Beat-and-raise validates the backlog thesis. Flat guide with rising SG&A validates the bear.
SG&A guided to $153M in Q1 versus $135M two quarters ago, a 13% increase against 1.7% guided revenue growth. Operating leverage running in reverse while management narrates acceleration.
“For the fourth quarter, we generated revenue of $801 million, slightly above the midpoint of our guidance of $790 million and 1.3% higher than the third quarter.”
Figures are extracted from the transcripts and checked in code: every quote appears word for word. Descriptive only: none of this feeds the verdict.
Book-to-bill of 1.2 with semis at 1.27. Backlog $1.3B, five months coverage, up 14% sequentially. Orders at three-year highs across every technology, channel, and region. Metals surcharge pushed through as industry first mover, second increase in the works, ASP declines below historical norms. Newport drag compressing from 130bps to 50-75bps guided, turning accretive by Q1 exit. 10,000 part numbers qualified through subcontractor initiative, freeing capacity for high-margin products. EMS channel now consistent after being negligible pre-Vishay 3.0. $400-440M capex committed, peak of five-year expansion, targeting a market short on diodes and MOSFETs. January B2B running hotter than Q4. Capital Conviction matches the narrative.
Q1 guide of $800-830M versus $801M actual is flat sequential growth dressed up as acceleration. SG&A jumped from $135M to $142M to a guided $153M across two quarters while revenue grows 1.7%. EBITDA margin fell from 9.6% to 8.8%. 42% of operating cash flow came from securitizing receivables, a financing activity. DSO improvement from 53 to 48 days is a screen trick. Company guides to negative FCF for 2026 while maintaining a $13.6M dividend funded by $219M in revolver draws and promising to return 70% of cash flow that will be negative. AI exposure is commodity power components with no structural moat. Automotive share gains from a geopolitical disruption event are 'starting small' pending Q1 audits. Distribution inventory drawing down at 22 weeks means channel is consuming, not stocking.
Say/Do Gap
SG&A guided to $153M in Q1 from $135M in Q3, a 13% increase in two quarters, against 1.7% guided revenue growth. Confidence language increased but guidance number did not follow. Operating leverage running in reverse.
AI Label Without Substance
AI exposure is multiphase DC-DC converters and tantalum polymer capacitors. Commodity products with no proprietary moat. The AI narrative carries the multiple while the power components carry no structural pricing advantage.
Backlog Quality
Orders driven partly by supply-securing against extended diode/MOSFET lead times and pre-Lunar New Year positioning. Distribution inventory fell from 23 to 22 weeks, meaning channel is drawing down not stocking up.
Inventory Divergence
Distribution inventory at 22 weeks and falling while orders hit three-year highs. Channel is consuming existing stock rather than replenishing, which inflates book-to-bill without confirming end demand.
HOLD. The order data is real and I will not short it. B2B of 1.2 with semis at 1.27 and backlog at $1.3B is not fabricated. But I cannot size a long position when SG&A is growing four times faster than revenue, 42% of operating cash flow is receivables securitization, and the CEO has to volunteer January order data in closing remarks because his own Q1 guide is flat. Wait for May. A beat-and-raise with margin at or above 19.9% earns a full position. Another flat quarter with rising SG&A earns a short on earnings quality.